Assessment of Herpesvirus saimiri as a potential human gene therapy vector
✍ Scribed by Stevenson, Alex J.; Cooper, Matthew; Griffiths, Joanne C.; Gibson, Paul C.; Whitehouse, Adrian; Jones, Elena F.; Markham, Alexander F.; Kinsey, Sally E.; Meredith, David M.
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 463 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Herpesvirus saimiri has characteristics that make it amenable to development as a gene therapy vector. The viral genome is thought to be capable of accommodating large quantities of heterologous DNA while the virus itself can infect many different cell types. Virus infection has been shown in many cases to be persistent by virtue of episomal maintenance in the target cell. In this article we examine the ability of nonselectable recombinant viruses expressing the beta-galactosidase gene product to infect a variety of human cells and demonstrate that this virus could be developed as an alternative hematopoietic stem cell gene therapy vector. In contrast to earlier observations, we demonstrate by a number of methods that the virus has the ability to replicate in many human cell types, suggesting the need for the development of a disabled virus for use as a gene therapy vector.
📜 SIMILAR VOLUMES
## Abstract Curcumin, the principle component of the spice turmeric, has been used as an anti‐inflammatory medication in India and China for centuries. Recent studies, predominantly using actively dividing cell lines, have suggested that this compound could be used as a chemopreventative or therape
The bacterial enzyme cytosine deaminase (CD) catalyzes the conversion of 5-fluorocytosine (5-FC) to the lethal 5-fluorouracil (5-Fu) and so provides a useful system for selective killing of gene-modified mammalian tumor cells. Cloning of the CD gene from Escherichiu coli and expression in human tumo
## Abstract ## Background A gene therapy delivery system based on microcapsules enclosing recombinant cells engineered to secrete a therapeutic protein has been evaluated. The microcapsules are implanted intraperitoneally. In order to prevent cell immune rejection, cells are enclosed in non‐antige
## Abstract Water‐soluble hyper‐branched poly(ethylenimine)‐__graft__‐poly(caprolactone)‐__block__‐monomethoxyl‐poly(ethylene glycol) cationic copolymers (hy‐PEI‐PCL‐mPEG) have shown potential for gene delivery. The degradation behavior of this type of copolymer is studied. Effects of the molecular